Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies

被引：0
|
作者：
Macaluso, F. S. [1 ]
Ventimiglia, M. [2 ]
Orlando, A. [1 ]
机构：
[1] Villa Sofia Cervello Hosp, IBD Unit, Palermo, Italy
[2] Italian Minist Hlth, Directorate Gen Med Device & Pharmaceut Serv, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [21] Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Honap, Sailish
    Meade, Susanna
    Ibraheim, Hajir
    Irving, Peter M.
    Jones, Michael P.
    Samaan, Mark A.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (03) : 1018 - 1035
  • [22] Safety and Effectiveness of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Dahiya, Dushyant Singh
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (04) : 378 - 388
  • [23] Effectiveness and safety of Ustekinumab in patients with inflammatory bowel disease from the real-world study: A systematic review with meta-analysis of observational studies
    Zhou, He
    Wang, Fang
    Su, Song
    Shi, Yanting
    Wu, Tong
    Liang, Jie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 88 - 88
  • [24] Effectiveness and safety of Ustekinumab in patients with inflammatory bowel disease from the real-world study: A systematic review with meta-analysis of observational studies
    Zhou, He
    Wang, Fang
    Su, Song
    Shi, Yanting
    Wu, Tong
    Liang, Jie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 88 - 88
  • [25] Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study
    Ruth Garcia-Romero
    José Miguel Martinez de Zabarte Fernandez
    Gemma Pujol-Muncunill
    Ester Donat-Aliaga
    Oscar Segarra-Cantón
    Iñaki Irastorza-Terradillos
    Enrique Medina-Benitez
    Carlos José Ruiz-Hernández
    Marta Carrillo-Palau
    Ignacio Ros-Arnal
    Alejandro Rodriguez-Martínez
    Laura Escartin-Madurga
    Carolina Gutiérrez-Junquera
    Saioa Vicente-Santamaría
    Marta Velasco Rodriguez-Belvis
    Sonia Fernández-Fernández
    José Ramón Alberto-Alonso
    Montserrat Montraveta
    Ricardo Torres-Peral
    María Navalon-Rubio
    Víctor Manuel Navas-López
    Javier Martin de Carpi
    European Journal of Pediatrics, 2021, 180 : 3039 - 3040
  • [26] Systematic Review and Meta-analysis: Vedolizumab and Postoperative Complications in Inflammatory Bowel Disease
    Yung, Diana E.
    Horesh, Nir
    Lightner, Amy L.
    Ben-Horin, Shomron
    Eliakim, Rami
    Koulaouzidis, Anastasios
    Kopylov, Uri
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (11) : 2327 - 2338
  • [27] A posteriori dietary patterns and risk of inflammatory bowel disease: a meta-analysis of observational studies
    Khorshidi, Masoud
    Djafarian, Kurosh
    Aghayei, Elham
    Shab-Bidar, Sakineh
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2020, 90 (3-4) : 376 - 384
  • [28] Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease
    Amiot, Aurelien
    Grimaud, Jean-Charles
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Gagniere, Charlotte
    Vuitton, Lucine
    Viennot, Stephanie
    Aubourg, Alexandre
    Pelletier, Anne-Laure
    Bouguen, Guillaume
    Abitbol, Vered
    Bouhnik, Yoram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1593 - +
  • [29] Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
    Jin, Yu
    Lin, Yan
    Lin, Lian-Jie
    Zheng, Chang-Qing
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (20) : 6352 - 6360
  • [30] The efficacy, safety, and persistence of vedolizumab versus adalimumab in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Chen, Zhixin
    Li, Huo
    Li, Zhongzhuan
    Ouyang, Rong
    Huang, Shijiang
    Qin, Shufen
    Qin, Jing
    Huang, Jiean
    INFLAMMOPHARMACOLOGY, 2025, : 1761 - 1773
12345